NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054281

Registered date:01/05/2024

A study of changes in treatment satisfaction and its factors in patients treated with lecanemab

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedearly Alzheimer's disease
Date of first enrollment2024/05/01
Target sample size160
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeTreatment Satisfaction Questionnaire for Medication (TSQM) score
Secondary OutcomeNeuropsychiatric Inventory Questionnaire(NPI-Q) score, Everyday memory checklist(EMC) score, the presence of Amyloid Related Imaging Abnormalities(ARIA)

Key inclusion & exclusion criteria

Age minimum40years-old
Age maximum90years-old
GenderMale and Female
Include criteria
Exclude criteria1) Persons with uncontrolled physical illnesses. 2) Persons who have another nationality or speak a language other than Japanese as their mother tongue. Patients who meet the above criteria and their carers are excluded from the eligible participants.

Related Information

Contact

public contact
Name Yuto Satake
Address D3 2-2, Yamadaoka, Suita, Osaka, Japan Japan 565-871
Telephone 06-6879-3051
E-mail y.satake@psy.med.osaka-u.ac.jp
Affiliation Osaka University Graduate School of Medicine Department of Psychiatry
scientific contact
Name Manabu Ikeda
Address D3 2-2, Yamadaoka, Suita, Osaka, Japan Japan
Telephone 06-6879-3051
E-mail mikeda@psy.med.osaka-u.ac.jp
Affiliation Osaka University Graduate School of Medicine Department of Psychiatry